Table 1.
ccRCC patients' characteristics and correlations with RBMS2 expression level.
| Characteristics | Low expression of RBMS2 | High expression of RBMS2 | P value |
|---|---|---|---|
| n | 270 | 271 | |
| Gender, n (%) | 0.092 | ||
| Female | 84 (15.5%) | 103 (19%) | |
| Male | 186 (34.4%) | 168 (31.1%) | |
| Age, n (%) | 0.035 | ||
| ≤60 | 122 (22.6%) | 147 (27.2%) | |
| >60 | 148 (27.4%) | 124 (22.9%) | |
| Serum calcium, n (%) | 0.002 | ||
| Low | 90 (24.5%) | 114 (31.1%) | |
| Normal and elevated | 98 (26.7%) | 65 (17.7%) | |
| Histologic grade, n (%) | <0.001 | ||
| G1 and G2 | 96 (18%) | 154 (28.9%) | |
| G3 and G4 | 168 (31.5%) | 115 (21.6%) | |
| Pathologic T stage, n (%) | <0.001 | ||
| T1 and T2 | 150 (27.7%) | 200 (37%) | |
| T3 and T4 | 120 (22.2%) | 71 (13.1%) | |
| Pathologic N stage, n (%) | 0.400 | ||
| N0 | 125 (48.4%) | 117 (45.3%) | |
| N1 | 10 (3.9%) | 6 (2.3%) | |
| Pathologic M stage, n (%) | <0.001 | ||
| M0 | 201 (39.6%) | 228 (44.9%) | |
| M1 | 53 (10.4%) | 26 (5.1%) | |
| Pathologic stage, n (%) | <0.001 | ||
| Stage I and stage II | 138 (25.7%) | 194 (36.1%) | |
| Stage III and stage IV | 129 (24%) | 77 (14.3%) |